WI-PHILLIPS-MEDISIZE
Phillips-Medisize , a Molex company, announced the opening of a new Global Innovation and Development (GID) center in Copenhagen, Denmark to support long-term growth plans for its advanced injection, wearable devices and connected health technologies. The new center enables the company to accelerate creation of world-class and differentiated drug delivery devices for its global customer base, while providing an easily accessible hub for its European customers.
Copenhagen offers an optimal location from which to access top drug delivery and connectivity resources that complement existing Phillips-Medisize European centers in Struer, Denmark and Cambridge, UK. By establishing a presence in Copenhagen, Phillips-Medisize is in the middle of the Medicon Valley cluster, close to top universities, hospitals and global R&D-based pharmaceutical and medical device companies. This Scandinavian region is a natural entry point into Europe and is home to innovators exploring large unmet medical needs in areas such as oncology, diabetes and personalized medicine.
“The opening of our new Copenhagen GID center represents an exciting opportunity to expand our global footprint by supporting overall growth with closer proximity to current European clients, fortifying our business development efforts and attracting top talent in the region to join our growing team,” said Matt Jennings, CEO and President of Phillips-Medisize.
Phillips-Medisize’s new GID center is in Teknikerbyen, Vium, in the greater Copenhagen area. It is now operational with a leadership team in place. Recruitment efforts are underway to hire talent with pharma and medical device expertise in project management, quality assurance, regulatory affairs and engineering development across mechanical, software and electronics. The first hiring phase will include 30 employees, expandable to a 100-person workforce.
Currently, Phillips-Medisize operates GID sites in Europe, North American and Asia, most recently opening a Bangalore, India office. The company’s increased focus on healthcare innovation in Europe and investment in hiring top talent demonstrates its commitment to helping customers develop more intelligent drug delivery and connected health solutions that address patient needs.
About Phillips-Medisize:
Phillips-Medisize, LLC, a Molex company, is an end-to-end provider of innovation, development and manufacturing solutions to the pharmaceutical, diagnostics, and medical device market segments. Backed by the combined global resources of Molex and its parent company Koch Industries, Phillips-Medisize’s core advantage is the knowledge of its people to integrate design, molding, electronics, and automation, providing innovative, high-quality manufacturing solutions. For more information, please visit www.phillipsmedisize.com or www.molex.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191112005778/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial Evaluating Abluminus NP Polymer-Free DES22.1.2026 13:00:00 CET | Press release
Concept Medical Inc., a global pioneer in innovative drug delivery technology, is proud to announce the successful enrollment of the first patients in the STARS DAPT (ST-Segment Elevation Myocardial InfArction treated with a Polymer-Free Sirolimus-based NanocarrieR Eluting Stent and a P2Y12 inhibitor-based Single Antiplatelet Strategy after a Short Dual Antiplatelet Therapy versus conventional Dual AntiPlatelet Therapy) randomized controlled trial. This trial marks a significant milestone in evaluating the breakthrough technology of polymer free drug eluting stent (DES) for the treatment of STEMI patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121338054/en/ Concept Medical announces first patient enrollment in the STARS DAPT randomized clinical trial evaluating Abluminus™ NP polymer-free DES The first four patients were enrolled by (Professor Barbara Stähli and her team at the University Hospital of Zurich in Swi
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing22.1.2026 12:00:00 CET | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request to continue its listing on the Nasdaq Stock Market, subject to stated conditions focused on timely completion of its financial audit and remediation of filing delinquencies. Under the Panel’s decision, SINOVAC must, on or before May 11, 2026, demonstrate compliance with Nasdaq Listing Rule 5250(c)(1) and Listing Rule 5250(c)(2) by completing filings of its annual report for the year ended December 31, 2024 on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of year 2025 on Form 6-K. As disclosed on January 4, 2026, the Company has engaged Zhonghua Certified Public Accountants LLP (“Zhonghua”) as its independent registered public accounting firm. SINOVAC is working diligently with Zhonghua to complete the required audit and t
Sisvel Launches Wi-Fi Multimode Patent Pool22.1.2026 12:00:00 CET | Press release
Ten patent owners establish licensing solution covering Wi-Fi 6 and Wi-Fi 7 standards Sisvel has launched a groundbreaking Wi-Fi Multimode patent pool offering access to standard essential patents owned by 10 Wi-Fi 6 and Wi-Fi 7 technology leaders. As the successor to Sisvel’s highly successful Wi-Fi 6 patent pool – which, over a three-year period, closed agreements with nearly 40 companies, including Acer, Netgear, Cisco and HP – the new programme offers an efficient way to access essential Wi-Fi rights for years to come. The 10 founding patent owners in the Wi-Fi Multimode programme are Huawei, KPN, Mitsubishi Electric, Orange, Panasonic, Philips, Aegis 11 SA (a Sisvel affiliate), SK Telecom, Wilus and ZTE. In addition, Sony Group Corporation has taken a licence under the Wi-Fi Multimode programme. This early agreement with a sophisticated and globally recognised Wi-Fi leader and implementer underlines the pool’s strong value proposition and the efforts made by Sisvel to engage with
Otto Group Enables AI-driven Intelligent Robot Coordination With the Digital Twin Developed by Roboverse Reply22.1.2026 11:52:00 CET | Press release
Reply [EXM, STAR: REY] is supporting the global retailer Otto Group in implementing a central, AI-driven virtual control system for intelligent robotic orchestration. Developed as part of a strategic collaboration between Otto Group, Reply, and NVIDIA, the "Robotic Coordination Layer" enables the training, simulation, and orchestration of autonomous mobile robots and stationary systems, accelerating delivery times and enhancing service levels This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260122331989/en/ This initiative with the Otto Group and NVIDIA underscores Roboverse Reply’s role as an implementation partner for AI-powered robotics and Physical AI in logistics. At the centre is a high-fidelity digital twin, serving as a precise replica of the warehouse environment and accurately representing the positions, movements, and interactions of all robotic systems. Developed thanks to Roboverse Reply’s expertise in robotic int
Bureau Veritas Named Accredited EcoVadis Consulting Partner22.1.2026 11:30:00 CET | Press release
Bureau Veritas, a global leader in Testing, Inspection, and Certification services (TIC), has been named as an Accredited Consulting Partner by EcoVadis, the global standard for resilient, sustainable supply chains. Accredited Consulting Partners are formally equipped to help businesses complete sustainability assessments, review scores, and improve Environment, Labor and Human Rights, Ethics, and Sustainable Procurement practices. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260122971773/en/ Accredited Consulting Partners are carefully selected based on their experience and expertise and must complete rigorous training on EcoVadis’ methodology and assessment process through the EcoVadis Academy. To qualify, partners must demonstrate a deep understanding of local environmental, ethical and human rights regulations and issues, and have completed the EcoVadis assessment for their own business. “Becoming an EcoVadis Accredite
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom